Table 4 Safety outcomes
Control group N = 89 | Intervention group N = 82 | p value | |
|---|---|---|---|
KDIGO (N) | |||
KDIGO 0 | 1 (1.1%) | 0 | 0.9 |
KDIGO 1 | 51 (58.6%) | 53 (69.7%) | 0.2 |
KDIGO 2 | 6 (6.9%) | 4 (5.3%) | 0.7 |
KDIGO 3 | 29 (33.3%) | 19 (25.0%) | 0.3 |
Worsening of AKI | 67 (75.3%) | 46 (59.7%) | 0.03 |
Natremia ≤ 135 mmol/L (N) | 42 (47.2%) | 33 (42.9%) | 0.7 |
Natremia ≥ 145 mmol/L (N) | 40 (44.9%) | 40 (52%) | 0.5 |
Episode of hypokalemia (N) | 51 (57.3%) | 53 (68.8%) | 0.1 |
Duration of hypokalemia (d) | 1 [0–2] | 1 [0–4] | 0.2 |
Cardiac rhythm troubles (N) | |||
Atrial fibrillation | 14 (15.3%) | 9 (11.7%) | 0.5 |
Torsade de pointes | 0 | 1 (1.3%) | 0.5 |
Ventricular tachycardia | 2 (2.3%) | 2 (2.6%) | 0.9 |
Ventricular fibrillation | 2 (2.3%) | 1 (2.6%) | 0.9 |